These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7318194)

  • 1. [Effect of fluoxymesterone on anaemia in chronic haemodialysis--special reference to combination therapy with iron (author's transl)].
    Kataoka Y
    Horumon To Rinsho; 1981 Jun; 29(6):675-82. PubMed ID: 7318194
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous iron and anaemia in haemodialysis patients.
    Shaldon S
    Nephron; 1998 Dec; 80(4):485. PubMed ID: 9832655
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of iron therapy in patients in long-term haemodialysis (author's transl)].
    Serra A; Morlans M; Olmos A; Camps J; Rodríguez JA; Carreras A; Soriano B; Bartolomé J; Piera L
    Med Clin (Barc); 1982 Apr; 78(8):313-7. PubMed ID: 7087599
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anemia in chronic hemodialysis; comparative value of iron therapy administered by oral and intravenous routes].
    Ducros J; Benas P; Salvadori JM; Olmer M
    J Urol Nephrol (Paris); 1977 Sep; 83(9):735-8. PubMed ID: 926237
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical effects of oral fluoxymesterone in patients with dialysis-controlled uremia.
    Lindholm DD; Fisher JW; Vieira JA; Dombeck DH; Bernal G; Lerthora J
    Trans Am Soc Artif Intern Organs; 1973; 19():475-83. PubMed ID: 4722764
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of IV iron in the treatment of anaemia of ESRD patients on maintenance haemodialysis: an historical and personal view.
    Shaldon S
    Nephrol Dial Transplant; 2007 Jan; 22(1):23-5. PubMed ID: 17088269
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of a small dose of fluoxymesterone on aplastic anemia (author's transl)].
    Miyazaki T; Motoji T
    Rinsho Ketsueki; 1978 Jul; 19(7):877-86. PubMed ID: 702822
    [No Abstract]   [Full Text] [Related]  

  • 8. Desferrioxamine improves anaemia in haemodialysis patients without aluminum or iron overload.
    Cuvelier R; Deceuninck P
    Nephrol Dial Transplant; 1988; 3(1):104. PubMed ID: 3132631
    [No Abstract]   [Full Text] [Related]  

  • 9. [Rise in serum creatinine under the androgen fluoxymesterone in chronic renal disease (author's transl)].
    Schulz E; Heinecke G
    MMW Munch Med Wochenschr; 1976 Nov; 118(48):1559-62. PubMed ID: 826797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral or parenteral iron therapy in haemodialysis patients?
    Winney RJ; Swainson CP; Parker AC; Bone JM; Robson JS
    Proc Eur Dial Transplant Assoc; 1977; 14():184-91. PubMed ID: 600955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anemia in chronic hemodialysis].
    Helbig W; Achenbach H; Löbe J; Gottschild D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1977; 104(2):242-57. PubMed ID: 69588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oral and i.v. iron therapy in haemodialysis patients (author's transl)].
    Rossi E; Serventi G; Venturini A; Arisi L; Bignardi L; Garini G; Savazzi G; Cambi V
    Ateneo Parmense Acta Biomed; 1976; 47(1):33-46. PubMed ID: 1016270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
    Stojimirović B; Grujić-Adanja G
    Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A study of anemia in 86 patients on hemodialysis (author's transl)].
    Serra A; Camps J; Morlans M; Olmos A; Carrera A; Soriano B; Rodríguez JA; Pelegrí A; Bartolomé J; Piera L
    Med Clin (Barc); 1981 May; 76(10):439-43. PubMed ID: 7242164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introduction to "A road map for intravenous iron and anemia management: preparing for the future".
    Coyne DW
    Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S1-4. PubMed ID: 19010256
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and safety of intravenous iron therapy for HCV-positive haemodialysis patients.
    Kahraman S; Yilmaz R; Genctoy G; Arici M; Altun B; Erdem Y; Yasavul U; Turgan C
    Nephron Clin Pract; 2005; 100(3):c78-85. PubMed ID: 15824511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled study of androgen therapy in anemia of patients on maintenance hemodialysis.
    Hendler ED; Goffinet JA; Ross S; Longnecker RE; Bakovic V
    N Engl J Med; 1974 Nov; 291(20):1046-51. PubMed ID: 4606387
    [No Abstract]   [Full Text] [Related]  

  • 18. Maintenance therapy with intravenous iron in hemodialysis patients receiving erythropoietin.
    Kotaki M; Uday K; Henriquez M; Blum S; Dave M
    Clin Nephrol; 1997 Jul; 48(1):63-4. PubMed ID: 9247787
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic guidelines for renal anemia in Japan].
    Naito M; Akiba T
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():562-5. PubMed ID: 15250369
    [No Abstract]   [Full Text] [Related]  

  • 20. Randomized trial on the therapeutic equivalence between Eprex and GerEPO in patients on haemodialysis.
    Goh BL; Ong LM; Sivanandam S; Lim TO; Morad Z;
    Nephrology (Carlton); 2007 Oct; 12(5):431-6. PubMed ID: 17803464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.